Free Trial
CVE:DBV

Doubleview Capital (DBV) Stock Price, News & Analysis

C$0.08
+0.01 (+7.14%)
(As of 05/7/2020)

About Doubleview Capital Stock (CVE:DBV)

Key Stats

Today's Range
C$0.07
C$0.08
50-Day Range
C$0.08
C$0.08
52-Week Range
C$0.04
C$0.14
Volume
86,000 shs
Average Volume
122,095 shs
Market Capitalization
C$8.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Doubleview Capital Corp. engages in the acquisition, exploration, and development of mineral resource properties in Canada. It explores for copper, gold, silver, and zinc deposits. The company holds interests in the Hat property with 10 mineral tenures totaling 6,308 hectares located in the northwestern British Columbia; and the Red Spring deposit situated to the north of Smithers, British Columbia. Doubleview Capital Corp. was incorporated in 2008 and is headquartered in Vancouver, Canada.

Receive DBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doubleview Capital and its competitors with MarketBeat's FREE daily newsletter.

DBV Stock News Headlines

Blackrock’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
DBV Technologies S.A. (DBV.PA)
See More Headlines

DBV Stock Analysis - Frequently Asked Questions

Doubleview Capital's stock was trading at C$0.08 at the beginning of 2024. Since then, DBV shares have increased by 0.0% and is now trading at C$0.08.
View the best growth stocks for 2024 here
.

Shares of DBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Doubleview Capital investors own include Tetra Bio-Pharma (TBPMF) and Cona Resources (CONA).

Industry, Sector and Symbol

Industry
Industrial Metals & Minerals
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
80
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Book Value
C$0.05 per share

Miscellaneous

Free Float
N/A
Market Cap
C$8.62 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (CVE:DBV) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners